Our observations strongly suggest that activating CREBH in the setting of established obesity, IR, and hepatic steatosis promotes weight loss and metabolic improvements by mechanisms that are at least, in part, attributable to increases in thermogenesis. This evidence concerns the gene CREB3L3 and obesity disorder.